DNA Sequencing Key Players | Innovation and Product Evolution | Market Entry and Expansion Strategies | Investment and Capital Allocation | Technology Commercialization | Market Trends Analysis | Future Market Positioning

DNA Sequencing Companies and Market Forecast

The DNA sequencing market size was estimated at US$ 12.42 billion in 2023 and is projected to grow to US$ 107.63 billion by 2034, rising at a compound annual growth rate (CAGR) of 21.69% from 2024 to 2034.

Top Companies in the DNA Sequencing:

• Agilent Technologies
• Element Biosciences
• Genewiz
• Illumina, Inc.
• Macrogen
• MGI
• OncoDNA
• Oxford Nanopore
• PacBio
• Perkin Elmer
• Qiagen
• Roche Diagnostics
• Thermo Fisher Scientific
• Wasatch BioLabs

Latest Announcements by Industry Leaders

Chad Carter, Vice President and General Manager of Microarray Genetic Solutions at Thermo Fisher Scientific, highlighted the importance of AI and automation in DNA sequencing. He commented that AI, coupled with innovation in microarray platforms, will accelerate genetic analysis and interpretation, enabling labs to take their genomic research to the next level.

Recent Developments in the DNA Sequencing Market

• In March 2024, Pacific Biosciences announced the launch of its PureTarget repeat expansion panel, a sequencing solution aimed at analyzing 20 genes linked to neurological disorders, such as Huntington’s disease and ALS. The panel is based on high-fidelity (HiFi) technology to target repeat expansions.
• In March 2024, researchers from Radboud University, Netherlands, shared positive results of a study using a novel technology, long-read HiFi, that sequences tens of thousands of base pairs to diagnose patients with a rare genetic disease.

If you have any questions, please feel free to contact us at sales@towardshealthcare.com